Shanghai Haohai Biological Technology Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2023: 0.023x

Shanghai Haohai Biological Technology Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Haohai Biological Technology Co. Ltd (5HB) has a cash flow conversion efficiency ratio of 0.023x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€141.99 Million ≈ $166.00 Million USD) by net assets (€6.09 Billion ≈ $7.12 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)

Cash flow conversion efficiency of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. This chart illustrates how Shanghai Haohai Biological Technology Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 5HB stock price for real-time trading data and today's change.

Shanghai Haohai Biological Technology Co. Ltd Cash Flow Conversion Ratio Explained

Shanghai Haohai Biological Technology Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Haohai Biological Technology Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Haohai Biological Technology Co. Ltd ranked by their cash flow conversion efficiency. Also see Shanghai Haohai Biological Technology Co stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
XXL ASA OL:XXL	-0.085x
Pmv Pharmaceuticals Inc NASDAQ:PMVP	-0.204x
JITF Infralogistics Limited NSE:JITFINFRA	0.364x
Sab Zenzele Kabili Holdings JSE:SZK	0.020x
Ybox Real Estate Ltd TA:YBOX	-0.067x
Tonix Pharmaceuticals Holding Corp NASDAQ:TNXP	-0.162x
Shalimar Paints Limited NSE:SHALPAINTS	-0.010x
Tridomain Performance Materials PT JK:TDPM	0.076x

Annual Cash Flow Conversion Efficiency for Shanghai Haohai Biological Technology Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. Review 5HB free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€5.60 Billion ≈ $6.55 Billion	€490.97 Million ≈ $574.00 Million	0.088x	-20.08%
2024-12-31	€5.92 Billion ≈ $6.92 Billion	€648.57 Million ≈ $758.25 Million	0.110x	+3.96%
2023-12-31	€6.02 Billion ≈ $7.03 Billion	€634.45 Million ≈ $741.74 Million	0.105x	+169.06%
2022-12-31	€5.90 Billion ≈ $6.90 Billion	€231.30 Million ≈ $270.41 Million	0.039x	-30.62%
2021-12-31	€6.06 Billion ≈ $7.09 Billion	€342.29 Million ≈ $400.17 Million	0.056x	+23.58%
2020-12-31	€5.73 Billion ≈ $6.70 Billion	€262.07 Million ≈ $306.39 Million	0.046x	-25.95%
2019-12-31	€5.65 Billion ≈ $6.61 Billion	€348.91 Million ≈ $407.91 Million	0.062x	-39.50%
2018-12-31	€3.84 Billion ≈ $4.48 Billion	€391.28 Million ≈ $457.45 Million	0.102x	+0.12%
2017-12-31	€3.37 Billion ≈ $3.94 Billion	€343.06 Million ≈ $401.07 Million	0.102x	+19.56%
2016-12-31	€2.99 Billion ≈ $3.49 Billion	€254.49 Million ≈ $297.52 Million	0.085x	--

About Shanghai Haohai Biological Technology Co. Ltd

F:5HB Germany Biotechnology

Market Cap

$73.19 Million

€62.60 Million EUR

Market Cap Rank

#20262 Global

#1842 in Germany

Share Price

€1.80

Change (1 day)

+3.45%

52-Week Range

€1.65 - €3.16

All Time High

€4.70